1,146
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Ameliorative effects of pyrazinoic acid against oxidative and metabolic stress manifested in rats with dimethylhydrazine induced colonic carcinoma

, , , , , , , , , , , & show all
Pages 304-313 | Received 27 Oct 2016, Accepted 19 Mar 2017, Published online: 16 May 2017

References

  • World Health Organisation. Global Cancer Facts & Figures, 2nd Edition, International agency for Research in Cancer. 2008; p 13; http://oralcancerfoundation.org/wp-content/uploads/2016/03/acspc-027766.pdf
  • Isnard-Bagnis C, Moulin B, Launay-Vacher V, Izzedine H, Tostivint I, Deray G. Renal toxicity of anticancer. Nephrol Ther 2005; 1:101-14; PMID:16895673; https://doi.org/10.1016/j.nephro.2004.12.001
  • Smith BD, Bambach BJ, Vala MS, Barber JP, Enger C, Brodsky RA, Burke PJ, Gore SD, Jones RJ. Inhibited apoptosis and drug resistance in acute myeloid leukaemia. Brit J Haematol 1998; 102:1042-9; PMID:9734656; https://doi.org/10.1046/j.1365-2141.1998.00854.x
  • Weiner IM, Tinker JP. Pharmacology of pyrazinamide: metabolic and renal function studies related to the mechanism of drug-induced urate retention. J Pharmacol Exp Ther 1972; 180(2):411-34; PMID:4622054
  • Zimic M, Fuentes P, Gilman RH, Gutiérrez AH, Kirwan D, Sheen P. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance. Tuberculosis 2012; 92(1):84-91; PMID:22004792; https://doi.org/10.1016/j.tube.2011.09.002
  • Lorenzen A, Stannek C, Lang H, Andrianov V, Kalvinsh I, Schwabe U. Characterization of a G protein-coupled receptor for nicotinic acid. Mol Pharmacol 2001; 59:349-57; PMID:11160872
  • Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, Mellinger JD, Smith SB, Digby GJ, Lambert NA, et al. GPR109A Is a G-protein–coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 2009; 69(7):2826-32; PMID:19276343; https://doi.org/10.1158/0008-5472.CAN-08-4466
  • Elangovan S, Pathania R, Ramachandran S, Ananth S, Padia RN, Lan L, Singh N, Martin PM, Hawthorn L, Prasad PD, et al. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. Cancer Res 2014; 74(4):1166-78; PMID:24371223; https://doi.org/10.1158/0008-5472.CAN-13-1451
  • Mielczarek M, Chrzanowska A, Scibior D, Skwarek A, Ashamiss F, Lewandowska K. Arginase as a useful factor for the diagnosis of colorectal cancer liver metastases. Int J Biol Markers 2006; 21:40-4; PMID:28207092; https://doi.org/10.5301/JBM.2008.4541
  • Al-Sohaily S, Biankin A, Leong R, Kohonen-Corish M, Warusavitarne J. Molecular pathways in colorectal cancer. J Gastroenterol Hepatol 2012; 27:1423-31; PMID:22694276; https://doi.org/10.1111/j.1440-1746.2012.07200.x
  • Mundade R, Imperiale TF, Prabhu L, Loehrer PJ, Lu T. Genetic pathways, prevention, and treatment of sporadic colorectal cancer. Oncoscience 2014; 1(6):400-6; PMID:25594038; https://doi.org/10.18632/oncoscience.59
  • Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Research 1995; 55:3785-9; PMID:7641194
  • Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, Capella G, Canzian F, Bellvitge Colorectal Cancer Study Group. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor α, NFKB1, and peroxisome proliferator-activated receptor γ with colorectal cancer. Cancer Res 2003; 63:3560-6; PMID:12839942
  • Berghella AM, Pellegrini P, Beato TD, Marini M, Tomei E, Adorno D, Casciani CU. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back. Cancer Immunol Immunother 1998; 45(5):241-9; PMID:9439647; https://doi.org/10.1007/s002620050439
  • Coussens LM, Werb Z. A review article Inflammation and cancer. Nature 2002; 420:860-7; PMID:12490959; https://doi.org/10.1038/nature01322
  • Jung HC, Eckmann L, Yang S-K, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95:55-65; PMID:7814646; https://doi.org/10.1172/JCI117676
  • Xia J, Sinelnikov IV, Han B, Wishart DS. MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic Acids Res 2015; 43:1-7; PMID:25505162; https://doi.org/10.1093/nar/gku1303
  • Gribbestad IS, Petersen SB, Fjøsne HE, Kvinnsland S, Krane J. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed 1994; 7:181-94; PMID:7946996; https://doi.org/10.1002/nbm.1940070405
  • Wang H, Wang L, Zhang H, Deng P, Chen J, Zhou B, Hu J, Zou J, Lu W, Xiang P, et al. 1H NMR-based metabolic profiling of human rectal cancer tissue. Molecular Cancer 2013; 12:121; PMID:24138801; https://doi.org/10.1186/1476-4598-12-121
  • Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget 2016; 7(20):29454-64; PMID:27107423; https://doi.org/10.18632/oncotarget.8762
  • Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007; 6:546-51; PMID:17269711; https://doi.org/10.1021/pr060470d
  • Kim S, Lee S, Maeng YH, Chang WY, Hyun JW, Kim S. Study of metabolic profiling changes in colorectal cancer tissues using 1D 1H HR-MAS NMR spectroscopy. Bull Korean Chem Soc 2013; 34(5):1467-72; https://doi.org/10.5012/bkcs.2013.34.5.1467
  • Asfour W, Almadi S, Haffar L. Thymoquinone suppresses cellular proliferation, inhibits VEGF production and obstructs tumor progression and invasion in the rat model of DMH-induced colon carcinogenesis. Pharmacol Pharm 2013; 4:7-17; https://doi.org/10.4236/pp.2013.41002
  • Sivaranjani A, Sivagami G, Nalini N. Chemopreventive effect of carvacrol on 1,2-dimethylhydrazine induced experimental colon carcinogenesis. J Cancer Res Ther 2016; 12(2):755-62; PMID:27461646; https://doi.org/10.4103/0973-1482.154925
  • Lodhi RL, Maity S, Kumar P, Saraf SA, Kaithwas G, Saha S. Evaluation of mechanism of hepatotoxicity of leflunomide using albino wistar rats. Afr J Pharm Pharmacol 2013; l7:1625-31; https://doi.org/10.5897/AJPP2013.3517
  • Saha S, Chan DSZ, Lee CY, Wong W, New LS, Chui WK, Yap CW, Chan EC, Ho HK. Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties. Eur J Pharmacol 2012; 697:13-23; PMID:23041271; https://doi.org/10.1016/j.ejphar.2012.09.021
  • Kushwaha PS, Raj V, Singh AK, Keshari AK, Saraf SA, Mandal SC, et al. Antidiabetic effects of isolated sterols from Ficus racemosa leaves. RSC Adv 2015; 5:35230-7 ; https://doi.org/10.1039/C5RA00790A
  • Saha S, New LS, Ho HK, Chui WK, Chan ECY. Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes. Toxicol Lett 2010; 195:135-41; PMID:20307632; https://doi.org/10.1016/j.toxlet.2010.03.010
  • Ong MM, Latchoumycandane C, Boelsterli UA. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. Toxicol Sci 2007; 97:205-13; PMID:17150972; https://doi.org/10.1093/toxsci/kfl180
  • Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarençon D, Agay D, Chancerelle Y, Multon E. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 2004; 5:1-10; PMID:14720307; https://doi.org/10.1186/1471-2172-5-3
  • Schaefer N, Tahara K, Websky VM, Wehner S, Pech T, Tolba R, Abu-Elmagd K, Kalff JC, Hirner A, Türler A. Role of resident macrophages in the immunologic response and smooth muscle dysfunction during acute allograft rejection after intestinal transplantation. Transpl Int. 2008; 21:778-91; PMID:18492123; https://doi.org/10.1111/j.1432-2277.2008.00676.x
  • Magierowska K, Magierowski M, Hubalewska-Mazgaj M, Adamski J, Surmiak M, Sliwowski Z, Kwiecien S, Brzozowski T. Carbon mmonoxide (co) released from tricarbonyldichloror uthenium (ii (co) dimer rm-2) in gastroprotection against experimental ethanol-induced gastric damage. PLoS One 2015; 10:e0140493; PMID:26460608; https://doi.org/10.1371/journal.pone.0140493
  • Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, et al. HMDB 3.0-The human metabolome database in 2013. Nucleic acids Res 2012; 1-7; PMID: 23161693; https://doi.org/10.1093/nar/gks1065
  • Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood serum. Anal Chem 1995; 67:793-811; PMID:7762816; https://doi.org/10.1021/ac00101a004
  • Guleria A, Bajpai NK, Rawat A, Khetrapal CL, Prasad N, Kumar D. Metabolite characterisation in peritoneal dialysis effluent using high resolution 1H and 1H 13C NMR spectroscopy. Magn Reson Chem 2014; 52:475-9; PMID:24912868; https://doi.org/10.1002/mrc.4094

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.